[Microvascular perfusion and cardiac function after revascularization assessed by myocardial contrast

W Y Jin1, T G Zhu1, H Chen1

  • 1Department of Cardiology, Beijing Key Laboratory of Early Prediction and Intervention of Acute Myocardial Infarction, Center for Cardiovascular Translational Research, Peking University People's Hospital, Beijing 100044, China.

Insights

Nearly 60% of ST-segment elevation myocardial infarction patients show abnormal microvascular perfusion after percutaneous coronary intervention, indicating impaired left ventricular function. Left anterior descending artery culprit lesions and intraoperative no-reflow are key risk factors.

Area of Science:

  • Cardiology
  • Echocardiography
  • Myocardial Perfusion Imaging

Context:

  • Acute ST-segment elevation myocardial infarction (STEMI) requires prompt revascularization.
  • Microvascular dysfunction can persist post-percutaneous coronary intervention (PCI), impacting outcomes.
  • Myocardial contrast echocardiography (MCE) assesses microvascular perfusion and ventricular function.

Purpose:

  • To evaluate microvascular perfusion and left ventricular (LV) function post-PCI in STEMI patients using MCE.
  • To identify clinical factors associated with abnormal microvascular perfusion.

Summary:

  • This cross-sectional study analyzed 123 STEMI patients undergoing PCI.
  • Abnormal myocardial perfusion was observed in 59.3% of patients.
  • Abnormal perfusion correlated with worse LV systolic (lower GLS) and diastolic (higher E/Em, WMSI) function.

Impact:

  • High incidence of abnormal perfusion post-PCI highlights the need for targeted interventions.
  • Left anterior descending artery as culprit vessel, intraoperative no/low-reflow, and peak troponin I are independent risk factors for abnormal perfusion.
  • Echocardiographic parameters like deceleration time, E/Em, and WMSI are independently associated with perfusion abnormalities.